InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (24 ops.)
Insider track record
ExecutiveDisclosed buys
0
Disclosed sells
24
T+90 hit rate
80%
T+90 mean return
+35.9%
Across 5 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Explore the complete record of transactions filed by Butchko Julia G., Directrice du Développement et de la Technologie. Officer active across 1 company, notably Immunovant, Inc.. Cumulatively, 29 disclosures have been logged. Breakdown: 0 buy · 24 sells. Total volume traded: €1.8m. History available since 3 August 2021. The latest transaction was disclosed on 21 August 2024 (Cession). Regulator: SEC (Form 4). All data is accessible without signup.
Declarations29 total
2,907 shares@ US$31.844.6% of flowCommon StockSEC:0001764013-24-000157:0
2,698 shares@ US$29.644.1% of flowCommon StockSEC:0001764013-24-000134:0
1,527 shares@ US$28.062.2% of flowCommon StockSEC:0001764013-24-000126:0
3,247 shares@ US$29.655.0% of flowCommon StockSEC:0001764013-24-000097:0
7,825 shares@ US$28.8011.8% of flowCommon StockSEC:0001764013-24-000077:0
1,053 shares@ US$31.181.7% of flowCommon StockSEC:0001764013-24-000071:0
54,978 shares0Common StockSEC:0001764013-24-000048:0
2,146 shares@ US$36.154.0% of flowCommon StockSEC:0001764013-24-000038:0
1,297 shares@ US$38.592.5% of flowCommon StockSEC:0001764013-24-000007:0
3,141 shares@ US$32.755.3% of flowCommon StockSEC:0001764013-23-000141:0
296 shares@ US$35.540.6% of flowCommon StockSEC:0001764013-23-000118:0
12,332 shares@ US$20.3012.9% of flowCommon StockSEC:0001764013-23-000101:0
1,470 shares@ US$19.731.5% of flowCommon StockSEC:0001764013-23-000077:0
1,544 shares@ US$15.271.2% of flowCommon StockSEC:0001764013-23-000051:0
100,188 shares0Common StockSEC:0001764013-23-000042:0
19 shares@ US$15.160.0% of flowCommon StockSEC:0001764013-23-000010:0
928 shares@ US$9.180.5% of flowCommon StockSEC:0001764013-22-000132:0
535 shares@ US$4.670.1% of flowCommon StockSEC:0001764013-22-000124:0
548 shares@ US$5.830.2% of flowCommon StockSEC:0001764013-22-000111:0
112,816 shares0Common StockSEC:0001764013-22-000103:0
510 shares@ US$4.270.1% of flowCommon StockSEC:0001764013-22-000078:0
460 shares@ US$4.020.0000% mcap0.2% of flowCommon StockSEC:0001764013-22-000071:0
492 shares@ US$3.790.0000% mcap0.2% of flowCommon StockSEC:0001764013-22-000047:0
541 shares@ US$4.720.0000% mcap0.3% of flowCommon StockSEC:0001764013-22-000043:0
6,381 shares@ US$5.900.0006% mcap4.6% of flowCommon StockSEC:0001764013-22-000037:0
25 of 29 declarations
About Butchko Julia G.
Julia G. Butchko is the Chief Development & Technology Officer at Immunovant, Inc. She oversees product development initiatives and the company's technology strategies. With significant experience in innovation and development, she is committed to advancing Immunovant's mission. Her expertise is crucial for the company's success.
